Priyanka S Rana[Author] - Search Results

Year	Number of Results
2017	2
2018	3
2019	1
2020	2
2021	3
2022	4
2023	6
2024	4
2025	1

1

The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial.

Malek E, Rana PS, Swamydas M, Daunov M, Miyagi M, Murphy E, Ignatz-Hoover JJ, Metheny L, Kim SJ, Driscoll JJ. Malek E, et al. Among authors: rana ps. Nat Commun. 2024 Aug 27;15(1):7388. doi: 10.1038/s41467-024-51442-2. Nat Commun. 2024. PMID: 39191755 Free PMC article. Clinical Trial.

2

Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity.

Rana PS, Ignatz-Hoover JJ, Guo C, Mosley AL, Malek E, Federov Y, Adams DJ, Driscoll JJ. Rana PS, et al. Mol Cancer Ther. 2024 Dec 3;23(12):1743-1760. doi: 10.1158/1535-7163.MCT-23-0931. Mol Cancer Ther. 2024. PMID: 39210605 Free PMC article.

3

Role of Kindlin 2 in prostate cancer.

Bialkowska K, El Khalki L, Rana PS, Wang W, Lindner DJ, Parker Y, Languino LR, Altieri DC, Pluskota E, Sossey-Alaoui K, Plow EF. Bialkowska K, et al. Among authors: rana ps. Sci Rep. 2024 Aug 27;14(1):19809. doi: 10.1038/s41598-024-70202-2. Sci Rep. 2024. PMID: 39191802 Free PMC article.

4

A Reverse-Osmosis Model of Apoptotic Shrinkage.

Rana PS, Model MA. Rana PS, et al. Front Cell Dev Biol. 2020 Oct 23;8:588721. doi: 10.3389/fcell.2020.588721. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33195250 Free PMC article.

5

The Role of WAVE2 Signaling in Cancer.

Rana PS, Alkrekshi A, Wang W, Markovic V, Sossey-Alaoui K. Rana PS, et al. Biomedicines. 2021 Sep 14;9(9):1217. doi: 10.3390/biomedicines9091217. Biomedicines. 2021. PMID: 34572403 Free PMC article. Review.

6

Current and Emerging Strategies to Treat Urothelial Carcinoma.

Rani B, Ignatz-Hoover JJ, Rana PS, Driscoll JJ. Rani B, et al. Among authors: rana ps. Cancers (Basel). 2023 Oct 8;15(19):4886. doi: 10.3390/cancers15194886. Cancers (Basel). 2023. PMID: 37835580 Free PMC article. Review.

7

Road testing new CAR design strategies in multiple myeloma.

Rana PS, Murphy EV, Kort J, Driscoll JJ. Rana PS, et al. Front Immunol. 2022 Aug 9;13:957157. doi: 10.3389/fimmu.2022.957157. eCollection 2022. Front Immunol. 2022. PMID: 36016950 Free PMC article. Review.

8

MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer.

McBean B, Abou Zeidane R, Lichtman-Mikol S, Hauk B, Speers J, Tidmore S, Flores CL, Rana PS, Pisano C, Liu M, Santola A, Montero A, Boyle AP, Speers CW. McBean B, et al. Among authors: rana ps. Int J Mol Sci. 2025 Mar 3;26(5):2245. doi: 10.3390/ijms26052245. Int J Mol Sci. 2025. PMID: 40076867 Free PMC article.

9

A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.

Alkrekshi A, Wang W, Rana PS, Markovic V, Sossey-Alaoui K. Alkrekshi A, et al. Cell Signal. 2021 Sep;85:110073. doi: 10.1016/j.cellsig.2021.110073. Epub 2021 Jul 3. Cell Signal. 2021. PMID: 34224843 Free PMC article. Review.

10

Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma.

Rana PS, Goparaju K, Driscoll JJ. Rana PS, et al. Front Oncol. 2023 Jun 8;13:1141851. doi: 10.3389/fonc.2023.1141851. eCollection 2023. Front Oncol. 2023. PMID: 37361580 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year